Biopharmaceutical Manufacturing Market

Table Of Content

Executive Summary
1. Introduction
Market Introduction
1. Market Definition
2. Scope of the Study
3. Market Structure
Research Methodology
1. Primary Research
2. Research Methodology
3. Assumptions & Exclusions
4. Secondary Data Sources
Market Factor Analysis
1. Value Chain Analysis: Biopharmaceutical Manufacturing Market
2. Porters Five Forces Analysis
  1. Bargaining Power of Suppliers
  2. Bargaining Power of Buyers
  3. Threat of Substitution
  4. Threat of New Entrants
  5. Competitive Rivalry
Market Dynamics
1. Drivers
2. Restraints
3. Opportunities
Recent Trends Analysis
Impact of COVID-19 on Biopharmaceutical Manufacturing Market
1. Pre and Post Covid -19 Market Scenario Analysis
2. Market Recovery Timeline and Challenge
3. Measures Taken by Top Players
Regulatory Landscape
Biopharmaceutical Manufacturing Market, By Molecule Type
1. Introduction
  1. Market Size and Forecast, By Molecule Type
2. Monoclonal Antibody
  1. Market Size and Forecast, By Region
3. Interferon
  1. Market Size and Forecast, By Region
4. Insulin
  1. Market Size and Forecast, By Region
5. Growth and Coagulation Factor
  1. Market Size and Forecast, By Region
6. Erythropoietin
  1. Market Size and Forecast, By Region
7. Vaccine
  1. Market Size and Forecast, By Region
8. Hormone
  1. Market Size and Forecast, By Region
9. Others
  1. Market Size and Forecast, By Region
Biopharmaceutical Manufacturing Market, By Application
1. Introduction
  1. Market Size and Forecast, By Application
2. Oncology
  1. Market Size and Forecast, By Region
3. Blood Disorder
  1. Market Size and Forecast, By Region
4. Metabolic Disease
  1. Market Size and Forecast, By Region
5. Infectious Disease
  1. Market Size and Forecast, By Region
6. Cardiovascular Disease
  1. Market Size and Forecast, By Region
7. Neurological Disease
  1. Market Size and Forecast, By Region
8. Immunology
  1. Market Size and Forecast, By Region
9. Other Applications
  1. Market Size and Forecast, By Region
Biopharmaceutical Manufacturing Market, By Drug Type
1. Introduction
  1. Market Size and Forecast, By Drug Type
2. Proprietary (Branded)
  1. Market Size and Forecast, By Region
3. Biosimilars
  1. Market Size and Forecast, By Region
Biopharmaceutical Manufacturing Market, By Drug Development Type
1. Introduction
  1. Market Size and Forecast, By Drug Development Type
2. Outsource
  1. Market Size and Forecast, By Region
3. In-house
  1. Market Size and Forecast, By Region
Biopharmaceutical Manufacturing Market, By Formulation
1. Introduction
  1. Market Size and Forecast, By Formulation
2. Injectables (IV, IM, SC)
  1. Market Size and Forecast, By Region
3. Inhalation/Nasal Sprays
  1. Market Size and Forecast, By Region
4. Other Formulations
  1. Market Size and Forecast, By Region
Biopharmaceutical Manufacturing Market, By Sales Channel
1. Introduction
  1. Market Size and Forecast, By Sales Channel
2. Retail Pharmacies
  1. Market Size and Forecast, By Region
3. Non-retail
  1. Market Size and Forecast, By Region
Regional Overview
1. Introduction
  1. Market Size and Forecast
2. North America
  1. Market Size and Forecast
    1. By Molecule Type
      1. Monoclonal Antibody
      2. Interferon
      3. Insulin
      4. Growth and Coagulation Factor
      5. Erythropoietin
      6. Vaccine
      7. Hormone
      8. Others
    2. By Application
      1. Oncology
      2. Blood Disorder
      3. Metabolic Disease
      4. Infectious Disease
      5. Cardiovascular Disease
      6. Neurological Disease
      7. Immunology
      8. Other Applications
    3. By Drug Type
      1. Proprietary (Branded)
      2. Biosimilars
    4. By Drug Development Type
      1. Outsource
      2. In-house
    5. By Formulation
      1. Injectables (IV, IM, SC)
      2. Inhalation/Nasal Sprays
      3. Other Formulations
    6. By Sales Channel
      1. Retail Pharmacies
      2. Non-retail
  2. U.S.
    1. By Molecule Type
      1. Monoclonal Antibody
      2. Interferon
      3. Insulin
      4. Growth and Coagulation Factor
      5. Erythropoietin
      6. Vaccine
      7. Hormone
      8. Others
    2. By Application
      1. Oncology
      2. Blood Disorder
      3. Metabolic Disease
      4. Infectious Disease
      5. Cardiovascular Disease
      6. Neurological Disease
      7. Immunology
      8. Other Applications
    3. By Drug Type
      1. Proprietary (Branded)
      2. Biosimilars
    4. By Drug Development Type
      1. Outsource
      2. In-house
    5. By Formulation
      1. Injectables (IV, IM, SC)
      2. Inhalation/Nasal Sprays
      3. Other Formulations
    6. By Sales Channel
      1. Retail Pharmacies
      2. Non-retail
  3. Canada
3. Europe
  1. Market Size and Forecast
    1. By Molecule Type
      1. Monoclonal Antibody
      2. Interferon
      3. Insulin
      4. Growth and Coagulation Factor
      5. Erythropoietin
      6. Vaccine
      7. Hormone
      8. Others
    2. By Application
      1. Oncology
      2. Blood Disorder
      3. Metabolic Disease
      4. Infectious Disease
      5. Cardiovascular Disease
      6. Neurological Disease
      7. Immunology
      8. Other Applications
    3. By Drug Type
      1. Proprietary (Branded)
      2. Biosimilars
    4. By Drug Development Type
      1. Outsource
      2. In-house
    5. By Formulation
      1. Injectables (IV, IM, SC)
      2. Inhalation/Nasal Sprays
      3. Other Formulations
    6. By Sales Channel
      1. Retail Pharmacies
      2. Non-retail
  2. U.K.
    1. By Molecule Type
      1. Monoclonal Antibody
      2. Interferon
      3. Insulin
      4. Growth and Coagulation Factor
      5. Erythropoietin
      6. Vaccine
      7. Hormone
      8. Others
    2. By Application
      1. Oncology
      2. Blood Disorder
      3. Metabolic Disease
      4. Infectious Disease
      5. Cardiovascular Disease
      6. Neurological Disease
      7. Immunology
      8. Other Applications
    3. By Drug Type
      1. Proprietary (Branded)
      2. Biosimilars
    4. By Drug Development Type
      1. Outsource
      2. In-house
    5. By Formulation
      1. Injectables (IV, IM, SC)
      2. Inhalation/Nasal Sprays
      3. Other Formulations
    6. By Sales Channel
      1. Retail Pharmacies
      2. Non-retail
  3. Germany
  4. France
  5. Spain
  6. Italy
  7. Russia
  8. Nordic
  9. Benelux
  10. Rest of Europe
4. APAC
  1. Market Size and Forecast
    1. By Molecule Type
      1. Monoclonal Antibody
      2. Interferon
      3. Insulin
      4. Growth and Coagulation Factor
      5. Erythropoietin
      6. Vaccine
      7. Hormone
      8. Others
    2. By Application
      1. Oncology
      2. Blood Disorder
      3. Metabolic Disease
      4. Infectious Disease
      5. Cardiovascular Disease
      6. Neurological Disease
      7. Immunology
      8. Other Applications
    3. By Drug Type
      1. Proprietary (Branded)
      2. Biosimilars
    4. By Drug Development Type
      1. Outsource
      2. In-house
    5. By Formulation
      1. Injectables (IV, IM, SC)
      2. Inhalation/Nasal Sprays
      3. Other Formulations
    6. By Sales Channel
      1. Retail Pharmacies
      2. Non-retail
  2. China
    1. By Molecule Type
      1. Monoclonal Antibody
      2. Interferon
      3. Insulin
      4. Growth and Coagulation Factor
      5. Erythropoietin
      6. Vaccine
      7. Hormone
      8. Others
    2. By Application
      1. Oncology
      2. Blood Disorder
      3. Metabolic Disease
      4. Infectious Disease
      5. Cardiovascular Disease
      6. Neurological Disease
      7. Immunology
      8. Other Applications
    3. By Drug Type
      1. Proprietary (Branded)
      2. Biosimilars
    4. By Drug Development Type
      1. Outsource
      2. In-house
    5. By Formulation
      1. Injectables (IV, IM, SC)
      2. Inhalation/Nasal Sprays
      3. Other Formulations
    6. By Sales Channel
      1. Retail Pharmacies
      2. Non-retail
  3. Korea
  4. Japan
  5. India
  6. Australia
  7. Singapore
  8. Taiwan
  9. South East Asia
  10. Rest of Asia-Pacific
5. Middle East and Africa
  1. Market Size and Forecast
    1. By Molecule Type
      1. Monoclonal Antibody
      2. Interferon
      3. Insulin
      4. Growth and Coagulation Factor
      5. Erythropoietin
      6. Vaccine
      7. Hormone
      8. Others
    2. By Application
      1. Oncology
      2. Blood Disorder
      3. Metabolic Disease
      4. Infectious Disease
      5. Cardiovascular Disease
      6. Neurological Disease
      7. Immunology
      8. Other Applications
    3. By Drug Type
      1. Proprietary (Branded)
      2. Biosimilars
    4. By Drug Development Type
      1. Outsource
      2. In-house
    5. By Formulation
      1. Injectables (IV, IM, SC)
      2. Inhalation/Nasal Sprays
      3. Other Formulations
    6. By Sales Channel
      1. Retail Pharmacies
      2. Non-retail
  2. UAE
    1. By Molecule Type
      1. Monoclonal Antibody
      2. Interferon
      3. Insulin
      4. Growth and Coagulation Factor
      5. Erythropoietin
      6. Vaccine
      7. Hormone
      8. Others
    2. By Application
      1. Oncology
      2. Blood Disorder
      3. Metabolic Disease
      4. Infectious Disease
      5. Cardiovascular Disease
      6. Neurological Disease
      7. Immunology
      8. Other Applications
    3. By Drug Type
      1. Proprietary (Branded)
      2. Biosimilars
    4. By Drug Development Type
      1. Outsource
      2. In-house
    5. By Formulation
      1. Injectables (IV, IM, SC)
      2. Inhalation/Nasal Sprays
      3. Other Formulations
    6. By Sales Channel
      1. Retail Pharmacies
      2. Non-retail
  3. Turky
  4. Saudi Arabia
  5. South Africa
  6. Egypt
  7. Nigeria
  8. Rest of MEA
6. LATAM
  1. Market Size and Forecast
    1. By Molecule Type
      1. Monoclonal Antibody
      2. Interferon
      3. Insulin
      4. Growth and Coagulation Factor
      5. Erythropoietin
      6. Vaccine
      7. Hormone
      8. Others
    2. By Application
      1. Oncology
      2. Blood Disorder
      3. Metabolic Disease
      4. Infectious Disease
      5. Cardiovascular Disease
      6. Neurological Disease
      7. Immunology
      8. Other Applications
    3. By Drug Type
      1. Proprietary (Branded)
      2. Biosimilars
    4. By Drug Development Type
      1. Outsource
      2. In-house
    5. By Formulation
      1. Injectables (IV, IM, SC)
      2. Inhalation/Nasal Sprays
      3. Other Formulations
    6. By Sales Channel
      1. Retail Pharmacies
      2. Non-retail
  2. Brazil
    1. By Molecule Type
      1. Monoclonal Antibody
      2. Interferon
      3. Insulin
      4. Growth and Coagulation Factor
      5. Erythropoietin
      6. Vaccine
      7. Hormone
      8. Others
    2. By Application
      1. Oncology
      2. Blood Disorder
      3. Metabolic Disease
      4. Infectious Disease
      5. Cardiovascular Disease
      6. Neurological Disease
      7. Immunology
      8. Other Applications
    3. By Drug Type
      1. Proprietary (Branded)
      2. Biosimilars
    4. By Drug Development Type
      1. Outsource
      2. In-house
    5. By Formulation
      1. Injectables (IV, IM, SC)
      2. Inhalation/Nasal Sprays
      3. Other Formulations
    6. By Sales Channel
      1. Retail Pharmacies
      2. Non-retail
  3. Mexico
  4. Argentina
  5. Chile
  6. Colombia
  7. Rest of LATAM
Competitive Landscape, 2024
1. Introduction
2. Biopharmaceutical Manufacturing Market Share Analysis, 2024 (%)
  1. Market Share Analysis, 2024
  2. Competition Ranking, 2024
  3. Key Developments & Growth Strategies
    1. Merger & Acquisition
    2. Product Launch
    3. Expansion
  4. Consolidated SWOT Analysis of Key Players
Company Profile
1. Hoffmann-La Roche Ltd
  1. Business Overview
  2. Financial Data
  3. Key Product Categories
  4. Recent Developments
2. Novartis AG
3. AbbVie Inc.
4. Johnson & Johnson Services, Inc.
5. Merck & Co., Inc.
6. Pfizer Inc.
7. Bristol-Myers Squibb Company
8. Sanofi
9. GSK plc.
10. AstraZeneca
11. Takeda Pharmaceutical Company Limited
12. Biogen
13. Eli Lilly and Company
14. Novo Nordisk A/S
15. Amgen Inc.

	


A PHP Error was encountered

Severity: Warning
Message:  Undefined array key "list_tbl_fig"
Filename: reports/toc.php
Line Number: 79


	Backtrace:
	
		
	
		
	
		
			
			File: /var/www/html/application/views/frontend/reports/toc.php

			Line: 79

			Function: _error_handler			

		
	
		
	
		
	
		
			
			File: /var/www/html/application/controllers/Web.php

			Line: 215

			Function: view			

		
	
		
	
		
			
			File: /var/www/html/index.php

			Line: 316

			Function: require_once

Check Discount

Get Free Sample

Buy Now

Key Topics Covered

Market Factors (Including Drivers and Restraint)
Market Trends
Market Estimates and Forcasts
Competitive Analysis
Future Market Opportunities

Biopharmaceutical Manufacturing Market Size, Share & Trends Analysis Report By Molecule Type, By Application, By Drug Type, By Drug Development Type, By Formulation, By Sales Channel, By Region (North. . . . .

Table Of Content

A PHP Error was encountered